Kevin Tan | Chief Financial Officer |
Carsten Brunn | President and Chief Executive Officer |
Peter Traber | Chief Medical Officer |
Kei Kishimoto | Chief Scientific Officer |
Kristen Kluska | Cantor Fitzgerald |
Yun Zhong | BTIG |
Yatin Suneja | Guggenheim Partners |
John Newman | Canaccord |
Raju Prasad | William Blair |
Boobalan Pachaiyappan | H.C. Wainwright |
Good day, and welcome to the Selecta Bio Second Quarter 2022 Earnings Release Conference Call. All participants will be in listen-only mode. [Operator Instructions] After today's presentation, there will be an opportunity to ask questions. [Operator Instructions] Please note this event is being recorded. I would now like to turn the conference over to Kevin Tan, Chief Financial Officer of Selecta Bio.